Delivery Order SPE2DB22D1106-SPE2DB24FEEA2
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $3,138.17 firm fixed-price delivery order for 4,560,123,368 units of the drug Ondansetron ODT 4 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA) and has a completion date of March 3, 2023. Amerisourcebergen is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued up to $999,999,999.00, and the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Ondansetron ODT 4 mg tablets. The $1,519.85 firm-fixed-price delivery order was placed by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency that procures medical supplies. The award is not associated with any set-aside program. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of 4,564,514,283 units of Ondansetron ODT 4 mg tablets. The $6,434.62 firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) on May 6, 2024, with a completion date of May 7, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,685.40, is a firm-fixed-price delivery order with a completion date of February 22, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 4,566,177,428 units of Ondansetron ODT 8 mg tablets. The $4,191.53 Firm Fixed Price Delivery Order was issued by the Defense Logistics Agency (DLA) on October 22, 2024, with a completion date of October 23, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- The federal government awarded a contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to supply Ondansetron HCL 8 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The Delivery Order contract, valued at $16,154.28, has a firm fixed price and an ultimate completion date of April 26, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,027.88 firm-fixed-price delivery order is for the supply of 4,564,249,199 units of the medication Ondansetron ODT 8 mg Tablet, with a completion date of April 12, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Ondansetron ODT 8 mg tablets. The award, made by the Defense Logistics Agency (DLA), is a Delivery Order under an Indefinite Delivery Contract (IDC) with a ceiling value of $4,354.88 and a period of performance through November 1, 2024. The contract is for Firm Fixed Price with no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 IDC with...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $6,078.92 firm-fixed-price delivery order is for 4,560,801,855 units of Ondansetron Orally Disintegrating Tablets, 8 mg, with an ultimate completion date of May 3, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,455.02 firm fixed-price delivery order is for the supply of 4 mg Ondansetron HCl tablets. The contract has a completion date of November 8, 2023 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEEA2Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $5,681.11 delivery order for 4,563,906,227 units of Ondansetron ODT 8 mg tablets. The contract has a firm fixed price and is set to expire on March 11, 2024. The award was made by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 3/8/24 |